Cyclacel Pharmaceuticals recently announced the first patient dosed in its Phase 1/2 study of oral fadraciclib in patients with advanced solid tumors and aggressive lymphomas. The trial used a streamlined study design and will determine the recommended Phase 2 dose. Once established, the trial will immediately enter a proof of concept, cohort stage trial with […]

A cell replacement therapy that uses retinal pigment epithelium-derived stem cells is showing the potential to restore retinal tissue in advanced age-related macular degeneration with geographic atrophy. “When we designed the trial, our aim was to stop or slow down the progression of geographic atrophy (GA), and much to our surprise, we found that this […]

The Capitol School in Tuscaloosa began voluntary COVID-19 testing Thursday, becoming the first school in the state to utilize a pool of federal money to provide free testing to students. “The (federal) money came, $146 million in July, and I called because UAB has been advertising it,” said Barbara Rountree, Capitol School director.